Brexit: See the latest updates here

This site uses cookies as described in our Cookies Policy. If you agree to our use of cookies, please continue to use our site. Read more

Have a Tracking Number? Enter here to track your shipment

Webinar: Clinical Trials in South Africa during and post COVID-19

Wednesday 22 July 2020
14:30 – 16:00 SAST / CEST | 13:30 - 15:00 BST | 08:30-11:00 EDT

To register for the webinar click here.


  • Overview of an Ongoing COVID-19 Vaccine Trial

  • Panel Discussion 1 - Pharma & CROs Perspectives:

    Clinical Trials Pipelines: A shift in global forecasting and investment due to the unexpected COVID-19.
    How this affects clinical studies coming to South Africa, from a Sponsor and Pharma perspective.

  • Panel Discussion 2 - The Changing Landscape & New Ethics Approaches In Clinical Trials

  • Panel Discussion 3 - COVID-19: Clinical Trial Continuity Of The Study Site:

    Site strategies under the new normal.
    Local public health care facilities: Johannesburg’s perspective on management of COVID-19.


Dr Clare L. Cutland, BSc., MBBCH, DCH, PhD (Wits)
Scientific Coordinator, African Leadership in Vaccinology Expertise (ALIVE), University of the Witwatersrand

Alex Lopes
Country Head - South Africa, Novartis

Marzelle Haskins
Pharma Ethics

Dr Essack Mitha
Newtown Clinical Research Centre, MeDiNova Site


Dr Michelle Middle MB.ChB, M.Pharm.Med
South African Clinical Trials Consulting

To register for the webinar click here.

TAGS   Webinar  COVID-19